1218791-23-1 Usage
Uses
Used in Organic Synthesis:
N-tert-Butyl-2-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline is used as a reagent in organic synthesis for cross-coupling reactions, leveraging the boron atom's ability to facilitate the formation of carbon-carbon bonds. This makes it a key component in the synthesis of complex organic molecules.
Used in Pharmaceutical Production:
In the pharmaceutical industry, N-tert-Butyl-2-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline serves as a building block for the development of various drugs. Its structural and electronic properties contribute to the creation of new medicinal compounds with potential therapeutic applications.
Used in Agricultural Chemicals:
N-tert-Butyl-2-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline is also utilized in the production of agricultural chemicals, where it may contribute to the development of new pesticides or other agrochemicals that can improve crop protection and yield.
Used in Material Science:
N-tert-Butyl-2-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline has potential applications in material science, where its unique properties can be harnessed to develop new materials with specific characteristics for various industrial uses.
Used in Polymer Chemistry:
Its application extends to polymer chemistry, where it may be used to synthesize new types of polymers with tailored properties for use in different fields, such as plastics, coatings, or adhesives.
Check Digit Verification of cas no
The CAS Registry Mumber 1218791-23-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,8,7,9 and 1 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1218791-23:
(9*1)+(8*2)+(7*1)+(6*8)+(5*7)+(4*9)+(3*1)+(2*2)+(1*3)=161
161 % 10 = 1
So 1218791-23-1 is a valid CAS Registry Number.
1218791-23-1Relevant articles and documents
BENZIMIDAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION
-
Page/Page column 122, (2011/06/25)
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salt thereof, wherein R1-R7 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, method